← Human Trials & Peer-Reviewed Studies
Investigation of glutathione concentrations in peritoneal fluid from women with and without endometriosis
Plain-language guide to PMID 12860343 (2003): controlled clinical trial study of Glutathione in 29 patients, endometriosis.
Key Facts
- PMID
- 12860343
- Journal
- European journal of obstetrics, gynecology, and reproductive biology
- Year
- 2003
- Study type
- Controlled Clinical Trial
- Authors
- Polak G et al. (5 authors)
- DOI
- 10.1016/s0301-2115(03)00076-9
What This Study Did, in Plain Language
What Was Tested
Researchers studied Glutathione in the context of endometriosis in this controlled clinical trial publication.
To evaluate the concentration of glutathione in PF of women with endometriosis.
Who Took Part
The abstract describes 29 patients taking part.
By PubMed's age tags, the people studied were adults, women only.
Twenty-one patients with endometriosis (I or II rAFS stage, n=11; III or IV rAFS stage, n=10), and 29 patients with follicular or dermoid ovarian cysts (n=17 and n=12, respectively).
What Was Measured
Topics PubMed links to this paper include Ascitic Fluid, Biomarkers, Dermoid Cyst, Diagnosis, Differential, Endometriosis, Glutathione and Luteal Phase.
What This Means in Plain Language
This is a controlled clinical trial of Glutathione in 29 patients in people with endometriosis.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
Its findings take up roughly 3 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2003 (European journal of obstetrics, gynecology, and reproductive biology), a journal based in Ireland.
More context: the Glutathione compound page, Endometriosis research.
Our Notes on the Compound
Glutathione: The body's main antioxidant.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.